Reply: Neuropsychiatric Symptoms in Parkinson's Disease

被引:0
|
作者
Aarsland, Dag [1 ,2 ]
Marsh, Laura [3 ,4 ]
Schrag, Anette [5 ]
机构
[1] Univ Oslo, Stavanger Univ Hosp, Ctr Old Age Med, Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Baylor Coll Med, Houston, TX 77030 USA
[4] Michael E DeBakey VA Med Ctr, Houston, TX USA
[5] UCL, Inst Neurol, London, England
关键词
DRUG-INDUCED PSYCHOSIS; CLOZAPINE;
D O I
10.1002/mds.23174
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:191 / 192
页数:2
相关论文
共 50 条
  • [1] An exploratory study of the efficacy and safety of yokukansan for neuropsychiatric symptoms in patients with Parkinson's disease
    Hatano, Taku
    Hattori, Nobutaka
    Kawanabe, Tadaaki
    Terayama, Yasuo
    Suzuki, Norihiro
    Iwasaki, Yasuo
    Fujioka, Toshiki
    JOURNAL OF NEURAL TRANSMISSION, 2014, 121 (03) : 275 - 281
  • [2] Cognitive and neuropsychiatric disorders In Parkinson's disease
    Rodriguez-Constenla, Iria
    Cabo-Lopez, Iria
    Bellas-Lamas, Paula
    Cebrian, Ernesto
    REVISTA DE NEUROLOGIA, 2010, 50 : S33 - S39
  • [3] Neuropsychiatric Issues in Parkinson's Disease
    Cooney, Jeffrey W.
    Stacy, Mark
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2016, 16 (05)
  • [4] Management of Neuropsychiatric Symptoms in Long-Term Care Residents with Parkinson's Disease A Retrospective Cohort Study
    Herrmann, Nathan
    Marras, Connie
    Fischer, Hadas D.
    Wang, Xuesong
    Anderson, Geoff M.
    Rochon, Paula A.
    DRUGS & AGING, 2013, 30 (01) : 19 - 22
  • [5] Neuropsychiatric aspects of Parkinson's disease.
    Aarsland D.
    Karlsen K.
    Current Psychiatry Reports, 1999, 1 (1) : 61 - 68
  • [6] Neuropsychiatric aspects of Parkinson’s disease: Recent advances
    Laura Marsh
    Ariel Berk
    Current Psychiatry Reports, 2003, 5 (1) : 68 - 76
  • [7] Recognition and treatment of neuropsychiatric disturbances in Parkinson's disease
    Akbar, Umer
    Friedman, Joseph H.
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2015, 15 (09) : 1053 - 1065
  • [8] Psychiatric symptoms in Parkinson's disease.
    Anderson K.E.
    Weiner W.J.
    Current Neurology and Neuroscience Reports, 2002, 2 (4) : 303 - 309
  • [9] Accuracy of screening instruments for detection of neuropsychiatric syndromes in Parkinson's disease
    Martinez-Martin, Pablo
    Leentjens, Albert F. G.
    de Pedro-Cuesta, Jesus
    Chaudhuri, Kallol Ray
    Schrag, Anette E.
    Weintraub, Daniel
    MOVEMENT DISORDERS, 2016, 31 (03) : 270 - 279
  • [10] Clozapine withdrawal symptoms in a Parkinson's disease patient
    Zesiewicz, TA
    Borra, S
    Hauser, RA
    MOVEMENT DISORDERS, 2002, 17 (06) : 1365 - 1367